Biocept, Inc., a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, announced that it has granted inducement stock options to purchase an aggregate of 83,120 shares of its common stock to 14 new employees.
December 31, 2020
· 3 min read